WO2003002072A1 - Compositions contenant un derive d'hyroxydiphenyl ether inhibant le developpemment des odeurs corporelles - Google Patents
Compositions contenant un derive d'hyroxydiphenyl ether inhibant le developpemment des odeurs corporelles Download PDFInfo
- Publication number
- WO2003002072A1 WO2003002072A1 PCT/FR2002/001788 FR0201788W WO03002072A1 WO 2003002072 A1 WO2003002072 A1 WO 2003002072A1 FR 0201788 W FR0201788 W FR 0201788W WO 03002072 A1 WO03002072 A1 WO 03002072A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- hydroxy
- diphenyl ether
- aluminum
- composition
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q15/00—Anti-perspirants or body deodorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/046—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/347—Phenols
Definitions
- the present invention relates to an aerosol device consisting of a container comprising an aerosol composition consisting, on the one hand, of a liquid phase (a) (or juice) comprising at least one derivative of hydroxydiphenyl ether and (b) of at least at least one particular propellant and by a means of distributing said aerosol composition as well as to the process for treating human body odors and in particular axillary using this device.
- Antiperspirants have the effect of limiting sweat flow. They generally consist of aluminum salts which, on the one hand, are irritating to the skin and which, on the other hand, reduce the sweat flow by modifying the cutaneous physiology, which is not satisfactory.
- Bactericidal substances inhibit the development of the skin flora responsible for axillary odors.
- Triclosan (2,4,4'-trichloro-2'-hydroxydiphenylether).
- the present invention thus firstly relates to an aerosol device consisting of a container comprising an aerosol composition and a means of dispensing said aerosol composition, the latter comprising a liquid phase (or juice) containing: a) at least one derivative of 'hydroxydiphenyl ethers of formula (1):
- Z and Z ' identical or different, denote H, a linear or branched C ⁇ -C 30 hydrocarbon radical, cyclic or acyclic, saturated or unsaturated, interrupted or not by one or more heteroatoms or carbonyl groups, substituted or not by one or more groups chosen from OH, NH 2 , halogen, carboxy or alkoxy
- At least one propellant selected from dimethyl ether, linear or branched alkanes containing from 2 to 6 carbon atoms or their mixtures.
- the concentration of compound (s) of formula (1) preferably varies from 0.001 to 20%, more preferably from 0.01 to 15% and even more preferably from 0.1 to 10% by weight per relative to the total weight of the composition.
- the propellant is chosen from dimethyl ether, volatile hydrocarbons such as n-butane, propane, isobutane and their mixtures.
- composition containing the compound (s) of formula (1) and the propellant (s) may be in the same compartment or in different compartments in the aerosol container.
- the concentration of propellant (s) generally varies from 5 to 90% by weight pressurized and more preferably from 15 to 70% by weight relative to the total weight of the pressurized composition.
- composition according to the invention may also contain deodorant active agents or antiperspirant active agents.
- deodorant active agents there may be mentioned for example, zinc pyrrolidone carboxylate (more commonly called zinc pidolate), zinc sulfate, zinc chloride, zinc lactate, zinc gluconate and zinc phenoisulfonate, 2,4,4'-trichloro-2'-hydroxydiphenylether (Triclosan), 2,4-dichloro-2 '-hydroxydiphenylether, 3', 4 ', 5'-trichlorosalicylanilide, 1- (3', 4'- dichlorophenyl) -3- (4'-chlorophenyl) urea (triclocarban) or 3,7,11-trimethyldodeca -2,5,10-trienol (Famesol).
- zinc pyrrolidone carboxylate more commonly called zinc pidolate
- zinc sulfate zinc chloride
- zinc lactate zinc gluconate
- zinc phenoisulfonate 2,4,4'-trichloro-2'-
- antiperspirant active agents there may be mentioned for example aluminum hydrochloride, aluminum chlorohydrex, aluminum chlorohydrex PEG, aluminum chlorohydrex PG, aluminum dichlorohydrate, aluminum dichlorohydrex PEG, aluminum dichlorohydrex PG, l aluminum sesquichlorohydrate, aluminum sesquichlorohydrex PEG, aluminum sesquichlorohydrex PG, aluminum sulfate, aluminum zirconium octachlorohydrate, aluminum zirconium pentachlorohydrate, aluminum zirconium tetrachlorohydrate, aluminum zirconium trichlorohydrate, metal complexes (such as aluminum or zirconium) with an amino acid and as described in US Pat. No. 3,792,068.
- Such complexes are generally known by the name ZAG.
- ZAG complexes usually have an Al / Zr quotient ranging from approximately 1.67 to 12.5 and a Metal / Cl quotient ranging from approximately 0.73 to 1.93.
- the preferred amino acid for preparing such ZAG complexes is glycine.
- glycine aluminum zirconium octachlorohydrex GLY, aluminum zirconium pentachlorohydrex GLY, aluminum zirconium tetrachlorohydrate GLY and aluminum zirconium trichlorohydrate-GLY.
- deodorant or antiperspirant active agents may be present in the composition according to the invention in an amount of approximately 0.001 to 20% by weight relative to the total composition, and preferably in an amount of approximately 0.1 to 10% by weight.
- the cosmetic composition according to the invention is conventionally formulated according to the form of presentation for which it is intended.
- a cosmetically acceptable vehicle which may in particular be essentially aqueous, or contain organic solvents and in particular CrC monoalcohols, preferably of ethanol to accelerate the evaporation of the product, or propylene glycol, dipropylene glycol or their ethers.
- the cosmetic composition according to the invention can also be formulated as a water-in-oil, oil-in-water emulsion, or as a triple water-in-oil-in-water emulsion (such emulsions are known and described for example by C. FOX in "Cosmetics and Toiletries” - November 1986 - Vol 101 - pages 101-112).
- the cosmetic composition according to the invention can also comprise cosmetic adjuvants chosen from fatty substances, gelling agents, emollients, softeners, antioxidants, opacifiers, stabilizers, anti-foaming agents, moisturizing agents, vitamins, perfumes, preservatives, surfactants, fillers, sequestrants, polymers, basifying or acidifying agents, perfumes, dyes, pigments, thickening agents, or any other ingredient usually used in cosmetics for this type of application .
- cosmetic adjuvants chosen from fatty substances, gelling agents, emollients, softeners, antioxidants, opacifiers, stabilizers, anti-foaming agents, moisturizing agents, vitamins, perfumes, preservatives, surfactants, fillers, sequestrants, polymers, basifying or acidifying agents, perfumes, dyes, pigments, thickening agents, or any other ingredient usually used in cosmetics for this type of application .
- the surfactants are preferably chosen from anionic, amphoteric or nonionic surfactants.
- the fatty substances can consist of an oil or a wax or a mixture thereof, petrolatum, paraffin, lanolin, hydrogenated lanolin, acetylated lanolin; they also include fatty acids, fatty alcohols such as lauric, cetyl, myristic, stearic, palmitic, oleic alcohol as well as 2-octyldodecanol, fatty acid esters such as glycerol monostearate, polyethylene glycol monostearate , isopropyl myristate, isoprppyl adipate, isopropyl palmitate, octyl palmitate, C12-C15 fatty alcohol benzoates (Finsolv TN from FINETEX), myristic alcohol polyoxypropylenated to 3 moles of propylene oxide (WITCONOL APM from WITCO), triglycerides of fatty acids in C ⁇ -C-js such as caprylic / capric acid triglycer
- oils are chosen from animal, vegetable, mineral or synthetic oils and in particular hydrogenated palm oil, hydrogenated castor oil, petroleum jelly oil, paraffin oil, purcellin oil (octanoate stearyl), silicone oils and isoparaffins.
- the waxes are chosen from animal, fossil, vegetable, mineral or synthetic waxes. Mention may in particular bees beeswaxes, Camauba, Candellila, sugar cane, Japanese waxes, ozokerites, Montan wax, microcrystalline waxes, paraffins, waxes and silicone resins.
- the thickeners preferably nonionic, can be chosen from guar gums and modified or unmodified celluloses such as hydroxypropylated guar gum, cetylhydroxyethylcellulose, silicas such as, for example, Bentone Gel MiO sold by the company NL INDUSTRIES or Veegum Ultra, sold by the company POLYPLASTIC.
- the cosmetic composition can comprise emollients, which contribute to a soft, dry feeling, non-sticky when the composition is applied to the skin.
- emollients can be chosen from products of the volatile silicone type, non-volatile silicones and other non-volatile emollients.
- Volatile silicones are defined in a known manner as volatile compounds at room temperature. Among these compounds, mention may be made of cyclic and linear volatile silicones of the dimethylsiloxane type, the chains of which comprise from 3 to 9 silicone residues. Preferably, cyclomethicones D4 or D5 are chosen.
- Non-volatile silicones are defined in a known manner as compounds with low vapor pressure at room temperature.
- polyalkylsiloxanes in particular linear polyalkylsiloxanes such as, for example, the linear polydimethylsiloxanes, or dimethicones, sold by the company Dow Corning under the name of "Dow Corning 200 Fluid”
- polyalkylarylsiloxanes such as, for example, polymethylphenylsiloxanes, sold by the company Dow Corning under the name of “Dow Corning 556 Fluid”
- polyether and siloxane copolymers such as, for example, dimethicone copolyols.
- nonvolatile emollients useful in the present invention include for example: hydrocarbon-based derivatives, mineral oils, fatty alcohols, alcohol esters of C 3 -C ⁇ 8 with acids C 3 -C ⁇ 8 , the esters of benzoic acid with alcohols in C ⁇ 2 -C ⁇ 8 and their mixtures, polyols in C 2 -C 6 preferably chosen from glycerol, propylene glycol or sorbitol, polymers of polalkylene glycol.
- the cosmetic composition according to the invention can thus be in the form of a lotion, cream or fluid gel distributed in aerosol spray, and in this regard contain the ingredients generally used in this type of product and well known to those skilled in the art. 'art.
- the dispensing means which forms part of the aerosol device, generally consists of a dispensing valve controlled by a dispensing head, itself comprising a nozzle by which the aerosol composition is vaporized.
- the container containing the pressurized composition can be opaque or transparent.
- the following aerosol device is produced in accordance with the invention by introducing the following juice and the propellants into an aerosol container provided with conventional dispensing means.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Dispersion Chemistry (AREA)
- Emergency Medicine (AREA)
- Cosmetics (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0108660 | 2001-06-29 | ||
| FR0108660A FR2826572B1 (fr) | 2001-06-29 | 2001-06-29 | Compositions contenant un derive d'hydroxydiphenyl ether inhibant le developpement des odeurs corporelles |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2003002072A1 true WO2003002072A1 (fr) | 2003-01-09 |
Family
ID=8864955
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/FR2002/001788 Ceased WO2003002072A1 (fr) | 2001-06-29 | 2002-05-28 | Compositions contenant un derive d'hyroxydiphenyl ether inhibant le developpemment des odeurs corporelles |
Country Status (2)
| Country | Link |
|---|---|
| FR (1) | FR2826572B1 (fr) |
| WO (1) | WO2003002072A1 (fr) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003086338A1 (fr) * | 2002-04-12 | 2003-10-23 | Ciba Specialty Chemicals Holding Inc. | Utilisation de derives d'hydroxydipheylether en tant qu'inhibiteurs d'arylsulfatase dans des deodorants et antisudorifiques |
| EP2719700A1 (fr) | 2008-01-09 | 2014-04-16 | Amura Therapeutics Limited | Derives de tetrhydrofur(3,2-b)pyrrol-3-one comme inhibiteurs des proteases de cysteine |
| US10533033B2 (en) * | 2015-01-06 | 2020-01-14 | Immunovaccine Technologies Inc. | Lipid A mimics, methods of preparation, and uses thereof |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1288747B (de) * | 1967-04-19 | 1969-02-06 | Henkel & Cie Gmbh | Verwendung von 2-Hydroxyd-diphenylaethern als Potenzierungsmittel in antimikrobiellen Mitteln |
| US5098693A (en) * | 1989-07-21 | 1992-03-24 | Cast Blast | Anti-irritant spray for use with cast and method of application |
| WO1997046218A2 (fr) * | 1996-06-04 | 1997-12-11 | Ciba Specialty Chemicals Holding Inc. | Formulations liquides concentrees comprenant un principe actif microbicide |
| US5902569A (en) * | 1995-03-10 | 1999-05-11 | Kao Corporation | Ultraviolet shielding composite fine particles, method for producing the same, and cosmetics |
| EP1053989A2 (fr) * | 1999-05-20 | 2000-11-22 | Ciba SC Holding AG | Composés hydroxyles d'éther diphénylique |
| WO2001084937A1 (fr) * | 2000-05-08 | 2001-11-15 | Novozymes A/S | Activite antimicrobienne induite par oxydoreductase |
-
2001
- 2001-06-29 FR FR0108660A patent/FR2826572B1/fr not_active Expired - Fee Related
-
2002
- 2002-05-28 WO PCT/FR2002/001788 patent/WO2003002072A1/fr not_active Ceased
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1288747B (de) * | 1967-04-19 | 1969-02-06 | Henkel & Cie Gmbh | Verwendung von 2-Hydroxyd-diphenylaethern als Potenzierungsmittel in antimikrobiellen Mitteln |
| US5098693A (en) * | 1989-07-21 | 1992-03-24 | Cast Blast | Anti-irritant spray for use with cast and method of application |
| US5902569A (en) * | 1995-03-10 | 1999-05-11 | Kao Corporation | Ultraviolet shielding composite fine particles, method for producing the same, and cosmetics |
| WO1997046218A2 (fr) * | 1996-06-04 | 1997-12-11 | Ciba Specialty Chemicals Holding Inc. | Formulations liquides concentrees comprenant un principe actif microbicide |
| EP1053989A2 (fr) * | 1999-05-20 | 2000-11-22 | Ciba SC Holding AG | Composés hydroxyles d'éther diphénylique |
| WO2001084937A1 (fr) * | 2000-05-08 | 2001-11-15 | Novozymes A/S | Activite antimicrobienne induite par oxydoreductase |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003086338A1 (fr) * | 2002-04-12 | 2003-10-23 | Ciba Specialty Chemicals Holding Inc. | Utilisation de derives d'hydroxydipheylether en tant qu'inhibiteurs d'arylsulfatase dans des deodorants et antisudorifiques |
| EP2719700A1 (fr) | 2008-01-09 | 2014-04-16 | Amura Therapeutics Limited | Derives de tetrhydrofur(3,2-b)pyrrol-3-one comme inhibiteurs des proteases de cysteine |
| US10533033B2 (en) * | 2015-01-06 | 2020-01-14 | Immunovaccine Technologies Inc. | Lipid A mimics, methods of preparation, and uses thereof |
| US10988500B2 (en) | 2015-01-06 | 2021-04-27 | Immunovaccine Technologies Inc. | Lipid A mimics, methods of preparation, and uses thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| FR2826572B1 (fr) | 2005-10-07 |
| FR2826572A1 (fr) | 2003-01-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2186544B1 (fr) | Utilisation de particules minérales amorphes expansées pour augmenter la rémanence d'un parfum ; composition parfumante, procédé de traitement des odeurs corporelles. | |
| EP1550435B1 (fr) | Composition déodorante du type émulsion huile-dans-eau contenant un mélange d'alkylpolyglycoside et d'alcool gras et un polyéther polyuréthane non-ionique associatif | |
| FR2781149A1 (fr) | Composition deodorante contenant un sel d'alun | |
| FR2973229A1 (fr) | Procede cosmetique de traitement des odeurs corporelles humaines utilisant un compose 4-(3-ethoxy-4-hydroxyphenyl)alkylcetone ou 2-ethoxy 4-hydroxyalkyl phenol | |
| FR3006178A1 (fr) | Utilisation cosmetique comme actif deodorant d'un materiau silicie obtenu par hydrolyse et condensation d'un tetraalcoxysilane et d'un c7-c20-alkyl trialcoxysilane | |
| EP1902754B1 (fr) | Composition déodorante hydroalcoolique comprenant un sel hydrosoluble de zinc et l'acide salicylique | |
| EP1486199B1 (fr) | Composition déodorante aérosol alcoolique contenant le salicylate de zinc | |
| FR2962328A1 (fr) | Procede de traitement des odeurs corporelles humaines utilisant une composition non rincee a base d'un compose 2-alcoxy-4-alkylcetone phenol et une huile essentielle | |
| FR2990850A1 (fr) | Composition cosmetique comprenant l'association d'un derive lipophile de l'acide salicylique, d'un sel ou complexe d'aluminium anti-transpirant et d'un sel d'acide amine n,n-diacide acetique | |
| FR2884417A1 (fr) | Composition cosmetique deodorante comprenant 'association d'un derive lipophile de l'acide salicylique et d'un sel d'aluminium anti-transpirant | |
| FR3012960A1 (fr) | Utilisation comme agent deodorant d'un derive salifie d'acide salicylique, seul ou en melange | |
| FR2826574A1 (fr) | Compositions contenant un derive d'hydroxydiphenyl ether inhibant le developpement des odeurs corporelles | |
| FR2863488A1 (fr) | Composition cosmetique deodorante comprenant l'association du gluconate de zinc et d'un seul sel d'aluminium anti-transpirant | |
| EP1541122B1 (fr) | Composition cosmétique déodorante comprenant l'association du pidolate de zinc et d'un sel d'aluminium anti-transpirant | |
| WO2003002072A1 (fr) | Compositions contenant un derive d'hyroxydiphenyl ether inhibant le developpemment des odeurs corporelles | |
| JP2002531474A (ja) | デオドラント化粧品組成物 | |
| FR3006177A1 (fr) | Utilisation cosmetique comme actif deodorant d'un materiau silicie obtenu par hydrolyse et condensation d'un tetraalcoxysilane et d'un aminoalkyl trialcoxysilane | |
| WO2003002078A1 (fr) | Compositions contenant un derive d'hydroxydiphenyl ether inhibant le developpement des odeurs corporelles | |
| FR2815856A1 (fr) | Utilisation de derives 1,3-diphenylpropane comme actifs inhibant le developpement des odeurs corporelles dans les compositions cosmetiques | |
| WO2001078673A2 (fr) | Composition cosmetique antitranspirante ne tachant pas les vetements | |
| FR2884414A1 (fr) | Composition cosmetique deodorante comprenant l'association du salicylate de zinc ou l'un de ses derives et d'un sel d'aluminium anti-transpirant | |
| EP0998909A1 (fr) | Composition déodorante | |
| WO2003002079A1 (fr) | Compositions contenant un derive d'hydroxydiphenyl ether inhibant le developpement des odeurs corporelles | |
| FR2884415A1 (fr) | Composition deodorante aerosol alcoolique contenant le chlorure de zinc ; dispositif aerosol ; procede de traitement des odeurs corporelles | |
| FR2826573A1 (fr) | Compositions contenant un derive d'hydroxydiphenyl ether inhibant le developpement des odeurs corporelles |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| ENP | Entry into the national phase |
Ref document number: 2004109815 Country of ref document: RU Kind code of ref document: A |
|
| ENP | Entry into the national phase |
Ref document number: 20040118 Country of ref document: UZ Kind code of ref document: A |
|
| ENP | Entry into the national phase |
Ref document number: 2004110036 Country of ref document: RU Kind code of ref document: A Ref document number: 2004110042 Country of ref document: RU Kind code of ref document: A |
|
| REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
| 122 | Ep: pct application non-entry in european phase | ||
| NENP | Non-entry into the national phase |
Ref country code: JP |
|
| WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |